Dr. Sri Nagalla Presents at NIH Workshop

Dr. Sri Nagalla, principle founder and member of ProteoGenix Board of Directors was an invited participant in NIH workshop, “Infections in the High Risk Newborn Infant” held, August 8-9, 2008. This workshop was co-sponsored by National Institute of Child Health and Development, National Institute of Neurological Disorders and Stroke (NINDS), and Office of Rare Diseases, and brought together leading clinical and academic experts. Dr. Nagalla presented on “Proteomic profiling for perinatal and neonatal infections".